home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9407a.zip
/
M9470089.TXT
< prev
next >
Wrap
Text File
|
1994-07-02
|
3KB
|
41 lines
Document 0089
DOCN M9470089
TI Effect of immunization with inactivated gp120-depleted human
immunodeficiency virus type 1 (HIV-1) immunogen on HIV-1 immunity, viral
DNA, and percentage of CD4 cells.
DT 9409
AU Trauger RJ; Ferre F; Daigle AE; Jensen FC; Moss RB; Mueller SH; Richieri
SP; Slade HB; Carlo DJ; Immune Response Corporation, Carlsbad,
California 92008.
SO J Infect Dis. 1994 Jun;169(6):1256-64. Unique Identifier : AIDSLINE
MED/94253583
AB A 1-year study measured the effect of administration of an inactivated
human immunodeficiency virus type 1 (HIV-1) immunogen in incomplete
Freund's adjuvant (IFA) on HIV-1-specific immunity and viral burden in
asymptomatic HIV-1-infected patients. A total of 103 patients were
enrolled in this double-blind, randomized study comparing immunogen in
adjuvant with adjuvant alone. This study was conducted at nine medical
centers throughout the United States. Significant differences in
cell-mediated immune responses to HIV-1 and p24 core antigen were
observed between the treated and control groups (P < .01). Compared with
controls, treated patients as a group had a significantly lower rate of
increase in viral DNA as determined by quantitative HIV-1 DNA-polymerase
chain reaction (P = .016). Significant differences in the rate of
percent CD4 cell decline were also observed between the 2 groups (P =
.024). These data suggest that augmentation of HIV-1-specific immunity
via immunotherapy may alter the rate of increase of HIV-1 DNA in
peripheral blood mononuclear cells and stabilize the percent of CD4 cell
decline in relatively healthy HIV-1-infected persons.
DE Adolescence Adult Antibody Formation AIDS Vaccines/ADMINISTRATION &
DOSAGE/*IMMUNOLOGY Double-Blind Method DNA, Viral/ANALYSIS Freund's
Adjuvant Human HIV Antibodies/IMMUNOLOGY HIV Envelope Protein
gp120/*IMMUNOLOGY HIV-1/*IMMUNOLOGY Immunity, Cellular/IMMUNOLOGY
Leukocyte Count Leukocytes, Mononuclear/MICROBIOLOGY Middle Age T4
Lymphocytes/CYTOLOGY/*IMMUNOLOGY Vaccination Vaccines,
Inactivated/ADMINISTRATION & DOSAGE/IMMUNOLOGY CLINICAL TRIAL JOURNAL
ARTICLE RANDOMIZED CONTROLLED TRIAL
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).